SECOND SIGHT MED PRODS INC's ticker is EYES and the CUSIP is 81362J209. A total of 35 filers reported holding SECOND SIGHT MED PRODS INC in Q4 2021. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,000 | – | 701 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Altium Capital Management LP | 373,867 | $1,847,000 | 0.43% |
| NewGen Asset Management Ltd | 200,000 | $988,000 | 0.37% |
| SABBY MANAGEMENT, LLC | 174,900 | $864,000 | 0.12% |
| Kepos Capital LP | 100,000 | $494,000 | 0.04% |
| Hudson Bay Capital Management LP | 380,404 | $1,879,000 | 0.02% |
| Paloma Partners Management Co | 139,081 | $687,000 | 0.01% |
| Cutler Group LLC / CA | 24,495 | $121,000 | 0.01% |
| Cutler Group LLC / CA | 35,000 | $36,000 | 0.00% |
| Stratos Wealth Partners, LTD. | 15,543 | $77,000 | 0.00% |
| Lake Point Wealth Management | 1,000 | $5,000 | 0.00% |